The Drugs for Neglected Diseases initiative’s Delali Attipoe, Director of the non-profit’s North America branch, discusses the rising risks of climate-sensitive diseases such as dengue. The Drugs for Neglected Diseases initiative’s Delali Attipoe, Director of the non-profit’s North America branch, discusses the rising risks of climate-sensitive diseases such as dengue.
There are 100–400 million Dengue fever infections each year, and cases are quickly rising. How can manufacturers develop reliable antivirals and vaccines?
- The collaboration will use AI to identify potential biological targets and therapies that could be repurposed for dengue to prevent disease progression - Dengue is a climate-sensitive